Global Hospital Acquired Infections (HAI) Diagnostics Market Size By Product (Reagents & Consumables And Instrument), By Infection Type (Urinary Tract Infections (UTI), Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections And Gastrointestinal Infections), By Test Type (Molecular Diagnostics, Immunoassay And Urinalysis), By Geographic Scope And Forecast

Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast

Hospital Acquired Infections (HAI) Diagnostics Market size was valued at USD 3.93 Billion in 2022 and is projected to reach USD 7.07 Billion by 2030, growing at a CAGR of 7.6% from 2023 to 2030.

The number of surgical operations performed annually has been rising gradually all over the world, and by the end of the decade, it is anticipated to reach a new high. The risk of Hospital Acquired Infections is anticipated to increase as the demand for surgical instruments increases along with the number of surgical procedures done. The market for invasive infection control equipment is anticipated to be boosted by a growing awareness of the importance of sterilized and disinfected medical equipment. The prevalence of chronic diseases and technological advancements in surgical tools are two additional factors influencing sales of infection control systems purchased by hospitals.

Global Hospital Acquired Infections (HAI) Diagnostics Market Definition

Hospital Acquired Infections (HAI) Diagnostics refers to the methods and tools used by healthcare professionals to diagnose infections that occur during a patient’s stay in a healthcare facility. These infections are also known as nosocomial infections. HAI diagnostics involves identifying the type of infection and determining its cause, such as a bacteria or virus. This is typically done through various laboratory tests, including blood tests, urine tests, and culture tests of the infected area.

The Diagnosis of HAI is critical in guiding appropriate treatment and preventing the spread of infection to other patients and healthcare workers. Early and accurate diagnosis can help healthcare providers choose the most effective treatment options, such as the appropriate antibiotics or antiviral medications. In addition to laboratory tests, healthcare providers may also use various imaging techniques, such as X-rays or CT scans, to diagnose HAI-related complications, such as pneumonia or abscesses.

Global Hospital Acquired Infections (HAI) Diagnostics Market Overview

In the upcoming years, it is anticipated that the company will experience significant growth. The growing elderly population base is one of the major factors influencing industry development. The geriatric population’s advancing age makes them more susceptible to diseases, which raises the demand for diagnostics. Increasing demand for HAI diagnostics from middle- and low-income countries like India and Brazil, the development of technologically sophisticated diagnostic products, rising awareness among healthcare professionals, and government initiatives to combat the prevalence of HAIs are additional factors supporting industry growth.

However, due to better healthcare infrastructure and increased awareness, nosocomial infection prevalence is anticipated to decline in developed countries, which will constrain industry development. Moreover, disinfection is a process that eliminates the majority or all pathogenic microorganisms, with the exception of bacterial spores from inert objects. It is done using liquid compounds or wet pasteurization. The effectiveness of disinfection has been affected by a number of variables, each of which could be restricted.

Since more medical procedures expose patients to the virus, disinfectants are being used more frequently in healthcare facilities to safeguard those performing those procedures. Surface disinfectants were desperately required during the COVID-19 epidemic, and it is anticipated that their demand will continue to rise.

Global Hospital Acquired Infections (HAI) Diagnostics MarketSegmentation Analysis

Global Hospital Acquired Infections (HAI) Diagnostics Market is segmented on the basis of Product, Infection Type, Test Type, and Geography.

Hospital Acquired Infections (HAI) Diagnostics Market, By Product

• Reagents & Consumables
• Instrument

On the Basis of Product, The market is split into Reagents & Consumables, and Instrument. Reagents and consumables are essential for performing laboratory tests to diagnose infections, including HAI. These may include test kits, culture media, and other materials used to collect and analyze patient samples. The demand for reagents and consumables is expected to continue to increase due to the growing prevalence of HAIs and the need for accurate and timely diagnosis.

Instruments, such as analyzers and diagnostic imaging equipment, are also important for diagnosing and treating HAIs. These instruments can help healthcare providers to identify the type and severity of the infection and determine the most appropriate course of treatment. The demand for diagnostic instruments is also expected to continue to grow as healthcare facilities invest in more advanced technologies and equipment to improve patient outcomes.

Hospital Acquired Infections (HAI) Diagnostics Market, By Infection Type

• Urinary Tract Infections (UTI)
• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Others

On the Basis of Infection Type, The market is split into Urinary Tract Infections (UTI), Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, and others. The Hospital Acquired Infections (HAI) Diagnostics Market is generally divided into pneumonia/lower respiratory infections, bloodstream infections (BSI), urinary tract infections (UTI), surgical site infections (SSI), and others such as cardiovascular and gastrointestinal infections. The industry for diagnosing pneumonia as a nosocomial infection is anticipated to experience the greatest growth in the industry during the forecast period, while the Hospital Acquired Infections (HAI) Diagnostics Market is expected to dominate the market with the largest share.

The industry is divided into molecular diagnostics and other IVD tests, such as urinalysis and blood tests, based on the kinds of tests. The segment for molecular diagnostics is anticipated to increase at the highest CAGR from 2023 to 2030. Some of the elements contributing to industry development in the near future consist of quick results with a shorter turnaround time, high sensitivity, and accuracy.

Hospital Acquired Infections (HAI) Diagnostics Market, By Test Type

• Molecular Diagnostics
• Immunoassay
• Urinalysis

On the Basis of Test Type, the global Hospital Acquired Infections (HAI) Diagnostics Market is classified into Molecular Diagnostics, Immunoassay, and Urinalysis. Molecular diagnostics, immunoassays, and urinalysis are all commonly used in the diagnosis of HAI, and each has its own advantages and limitations. Molecular diagnostics, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), are highly sensitive and specific, allowing for rapid and accurate detection of pathogens.

Immunoassays, which detect specific antibodies or antigens, can be useful for screening large populations and are often used in point-of-care settings. Urinalysis can provide valuable information about the presence of bacteria or other pathogens in the urinary tract. In terms of reagents and consumables, there is a wide range of products available for HAI diagnosis, including culture media, antibiotics, and various test kits. The instruments used for HAI diagnosis can also vary, from simple handheld devices to complex laboratory equipment.

Hospital Acquired Infections (HAI) Diagnostics Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

On the Basis of Geography, the global Hospital Acquired Infections (HAI) Diagnostics market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The company that operates in North America is projected to have the largest market share and grow at a significant rate. However, it is anticipated that during the review period, the industry in the Asia-Pacific region will expand at the highest CAGR of about 21%. The company is anticipated to experience further growth in the near future as a result of the rising prevalence of HAI in countries such as China and India.

Key Players

The “Global Hospital Acquired Infections (HAI) Diagnostics Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Abbott Laboratories, Danaher Corporation, Bayer AG, Becton, Dickinson and Company, Merck Group, Ecolab, Inc., Hologic, Inc., Steris PLC, Pfizer, Inc., Johnson & Johnson, and among others.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

• Alere, a company located in Massachusetts, will be acquired by Abbott, Inc. for USD 5.8 Billion, according to the announcement. Abbott has made this move to strengthen its position as a leader in point-of-care testing and to expand the breadth of its diagnostics solution offerings. Abbott aims to increase the number of infectious products it offers.
• In April 2020, For COVID-19, E25Bio has created an instant antigen test. The COVID-19 exam can be completed using this test in 15 minutes. The test is presently looking for FDA approval.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Hospital Acquired Infections (HAI) Diagnostics Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the global Hospital Acquired Infections (HAI) Diagnostics Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research